Issuer:
|
BioMed Realty, L.P. | |
Guarantor:
|
BioMed Realty Trust, Inc. | |
Ratings: (Moody’s / S&P)*
|
Baa3 / BBB- | |
Security Type:
|
Senior Unsecured Notes | |
Principal Amount:
|
$400,000,000 | |
Pricing Date:
|
March 23, 2011 | |
Settlement Date:
|
March 30, 2011 (T+5) | |
Maturity Date:
|
April 15, 2016 | |
Interest Payment Dates:
|
April 15 and October 15, beginning October 15, 2011 | |
Benchmark:
|
2.125% due February 29, 2016 | |
Benchmark Price / Yield:
|
100-12 3/4 / 2.04% | |
Spread to Benchmark:
|
+ 195 bps | |
Yield to Maturity:
|
3.99% | |
Coupon:
|
3.85% | |
Public Offering Price:
|
99.365% | |
Redemption Provisions:
|
At any time before 30 days prior to maturity at the Adjusted Treasury Rate plus 30 bps | |
| If the notes are redeemed on or after 30 days prior to the maturity date, the redemption price will be 100% of the principal amount of the notes being redeemed. | ||
CUSIP / ISIN:
|
09064A AF8 / US09064AAF84 | |
Joint Book-Running Managers:
|
Wells Fargo Securities, LLC | |
| KeyBanc Capital Markets Inc. | ||
| Morgan Stanley & Co. Incorporated | ||
Co-Managers:
|
Credit Suisse Securities (USA) LLC | |
| Deutsche Bank Securities Inc. | ||
| Raymond James & Associates, Inc. | ||
| UBS Securities LLC | ||
| RBS Securities Inc. | ||
| U.S. Bancorp Investments, Inc. | ||
| *Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. | ||
| The issuer has filed a registration statement (including a preliminary prospectus supplement and a prospectus) with the Securities and Exchange Commission (SEC) for the offering to which this communication relates. Before you invest, you should read the preliminary prospectus supplement for this offering, the issuer’s prospectus in that registration statement and any other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by searching the SEC online data base (EDGAR) on the SEC web site at http://www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus supplement and prospectus if you request it by calling Wells Fargo Securities, LLC toll-free at 1-800-326-5897; KeyBanc Capital Markets Inc. at 1-866-227-6479; or Morgan Stanley & Co. Incorporated toll-free at 1-866-718-1649. |